Ed Mathers has joined New Enterprise Associates as a partner, with a focus on biotech and specialty pharma opportunities. He previously was with MedImmune as executive VP of corporate development and venture.
New Enterprise Associates, Inc. (NEA), a leading global venture capital firm, today announced that Edward “Ed” T. Mathers has joined the firm as Partner. Mr. Mathers, a biopharmaceutical industry veteran with more than 25 years of experience, will focus on healthcare investments in key strategic areas including biotechnology and specialty pharmaceuticals.
“Ed's highly successful track record of strategic portfolio development across a range of technologies, disease targets and clinical stages adds significant depth to NEA's biopharmaceuticals investing practice, and we're thrilled to welcome him to the firm,” said Ryan Drant, General Partner. “His corporate development and venture capital investing experience brings a valuable perspective to our team, and we look forward to working with Ed as we continue to advance our portfolio of promising healthcare companies.”
Prior to joining NEA, Mr. Mathers most recently served as Executive Vice President, Corporate Development and Venture, at MedImmune, Inc. In this role, he was responsible for the company's licensing and business development activities and led the company's venture capital subsidiary, MedImmune Ventures, Inc. Before joining MedImmune in 2002, he was Vice President, Marketing and Corporate Licensing and Acquisitions at Inhale Therapeutic Systems. Mr. Mathers spent 15 years at Glaxo Wellcome, Inc. (GlaxoSmithKline), where he held sales and marketing positions of increasing responsibility. He started his career at Ortho Pharmaceuticals Corporation, a division of Johnson & Johnson, as a researcher. Mr. Mathers currently sits on the boards of directors of Kemia, Inc. and Plexxikon Inc.
New Enterprise Associates, Inc. (NEA) is a leading venture capital firm focused on helping entrepreneurs create and build major new enterprises that use technology to improve the way we live, work and play. Since its founding in 1978, the firm has followed the same core principles: supporting its entrepreneurs, providing an excellent return to its limited partners, and practicing its profession with the highest standards and respect. Through its affiliated funds, NEA focuses on investments at all stages of a company's development, from seed stage through IPO. With approximately $8.5 billion in committed capital, NEA's experienced management team has invested in over 600 companies, of which more than 160 have gone public and more than 240 have been acquired. NEA has U.S. offices in Chevy Chase, Maryland; Menlo Park, California; and Baltimore, Maryland. In addition, New Enterprise Associates (India) Pvt. Ltd. has an office in Bangalore, India and New Enterprise Associates (Beijing), Ltd. has offices in Beijing and Shanghai, China. For additional information, visit http://www.nea.com.